603127 昭衍新药
已收盘 05-21 15:00:00
资讯
新帖
简况
5月21日昭衍新药现10笔大宗交易 机构净买入735.93万元
证券之星 · 05-21 17:48
5月21日昭衍新药现10笔大宗交易 机构净买入735.93万元
5月21日昭衍新药创60日新高，易方达医疗保健行业混合A基金重仓该股
证券之星 · 05-21 16:27
5月21日昭衍新药创60日新高，易方达医疗保健行业混合A基金重仓该股
昭衍新药早盘涨超7% 公司产能利用率维持在较高水平
新浪港股 · 05-21 10:40
昭衍新药早盘涨超7% 公司产能利用率维持在较高水平
异动快报：昭衍新药（603127）5月21日10点14分触及涨停板
证券之星 · 05-21 10:15
异动快报：昭衍新药（603127）5月21日10点14分触及涨停板
食蟹猴供应仍然偏紧！昭衍新药一季度新签订单金额增长111.6%，核心业务亏损
红星资本局 · 05-20 11:36
食蟹猴供应仍然偏紧！昭衍新药一季度新签订单金额增长111.6%，核心业务亏损
芯片下沉，AI硬件全面开花
钛媒体 · 05-20 08:28
芯片下沉，AI硬件全面开花
每周股票复盘：昭衍新药（603127）将召开2025年年度股东会
证券之星 · 05-17
每周股票复盘：昭衍新药（603127）将召开2025年年度股东会
港股午评|恒生指数早盘跌0.87% 机器人板块逆市大涨
智通财经 · 05-15
港股午评|恒生指数早盘跌0.87% 机器人板块逆市大涨
港股异动 | 昭衍新药(06127)逆市涨超7% 一季度归母净利同比增近4.8倍 新签订单延续高景气度增长
智通财经 · 05-15
港股异动 | 昭衍新药(06127)逆市涨超7% 一季度归母净利同比增近4.8倍 新签订单延续高景气度增长
异动快报：昭衍新药（603127）5月15日9点46分触及涨停板
中金财经 · 05-15
异动快报：昭衍新药（603127）5月15日9点46分触及涨停板
昭衍新药(06127)将于8月4日派发末期股息每股0.12元
智通财经 · 05-12
昭衍新药(06127)将于8月4日派发末期股息每股0.12元
每周股票复盘：昭衍新药（603127）H股A股股本无变动
证券之星 · 05-10
每周股票复盘：昭衍新药（603127）H股A股股本无变动
股市必读：昭衍新药一季报 - 第一季度单季净利润同比增长479.67%
证券之星 · 05-06
股市必读：昭衍新药一季报 - 第一季度单季净利润同比增长479.67%
每周股票复盘：昭衍新药（603127）Q1净利增479.67%
证券之星 · 05-02
每周股票复盘：昭衍新药（603127）Q1净利增479.67%
昭衍新药（603127）2026年一季报简析：营收净利润同比双双增长
证券之星 · 05-01
昭衍新药（603127）2026年一季报简析：营收净利润同比双双增长
昭衍新药（603127）披露2026年A股限制性股票激励计划（草案），4月30日股价上涨0.6%
证券之星 · 04-30
昭衍新药（603127）披露2026年A股限制性股票激励计划（草案），4月30日股价上涨0.6%
昭衍新药(06127)一季度归母净利润2.38亿元 同比增加479.67%
智通财经网 · 04-29
昭衍新药(06127)一季度归母净利润2.38亿元 同比增加479.67%
4月28日昭衍新药涨7.31%，易方达医疗保健行业混合A基金重仓该股
证券之星 · 04-28
4月28日昭衍新药涨7.31%，易方达医疗保健行业混合A基金重仓该股
别只盯着AI！CXO龙头绩后狂飙，医药赛道要接棒？
格隆汇 · 04-28
别只盯着AI！CXO龙头绩后狂飙，医药赛道要接棒？
每周股票复盘：昭衍新药（603127）将发布一季度业绩
证券之星 · 04-19
每周股票复盘：昭衍新药（603127）将发布一季度业绩
公司概况
公司名称：
北京昭衍新药研究中心股份有限公司
所属行业：
研究和试验发展
上市日期：
2017-08-25
主营业务：
北京昭衍新药研究中心股份有限公司的主营业务是以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是。公司同时具备中国NMPA、美国FDA、经合组织OECD、韩国MFDS、日本PMDA等GLP资质；2025年9月公司北京及太仓设施通过了OECD的GLP现场检查及复查。
发行价格：
12.51
{"stockData":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":42.77,"timestamp":1779346800000,"preClose":38.88,"halted":0,"volume":60706542,"delay":0,"changeRate":0.1001,"floatShares":630000000,"shares":749000000,"eps":0.6607,"marketStatus":"已收盘","change":3.89,"latestTime":"05-21 15:00:00","open":38.89,"high":42.77,"low":38.89,"amount":2552000000,"amplitude":0.0998,"askPrice":0,"askSize":0,"bidPrice":42.77,"bidSize":2922,"shortable":0,"etf":0,"ttmEps":0.6607,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779413400000},"marketStatusCode":5,"adr":0,"adjPreClose":38.88,"symbolType":"stock","openAndCloseTimeList":[[1779327000000,1779334200000],[1779339600000,1779346800000]],"highLimit":42.77,"lowLimit":34.99,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":749348220,"isCdr":false,"pbRate":3.75,"roa":"--","peRate":64.734373,"roe":"2.82%","epsLYR":0.4,"committee":0,"marketValue":32050000000,"turnoverRate":0.0963,"status":0,"hkstockBrief":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":20.68,"timestamp":1779350895007,"preClose":19.63,"halted":0,"volume":6552043,"delay":0,"premium":"-58.03"},"floatMarketCap":26960000000},"requestUrl":"/m/hq/s/603127/wiki","defaultTab":"wiki","newsList":[{"id":"2637381642","title":"5月21日昭衍新药现10笔大宗交易 机构净买入735.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637381642","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637381642?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:48","pubTimestamp":1779356918,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日昭衍新药发生大宗交易，交易数据如下：近三个月该股共发生10笔大宗交易，合计成交4.02万手，折价成交10笔。该股近期无解禁股上市。截至2026年5月21日收盘，昭衍新药报收于42.77元，上涨10.01%，涨停，换手率9.63%，成交量60.71万手，成交额25.52亿元。该股近半年内有股东持股变动，合计净减持487.53万股，股东增减持明细如下表：该股最近90天内共有8家机构给出评级，买入评级7家，增持评级1家；过去90天内机构目标均价为44.32。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100033117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK0216","BK1576","603127","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637740383","title":"5月21日昭衍新药创60日新高，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637740383","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637740383?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:27","pubTimestamp":1779352067,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日昭衍新药涨10.01%创60日新高，收盘报42.77元，换手率9.63%，成交量60.71万手，成交额25.52亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共44家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为32.51亿元，最新净值3.742，较上一交易日上涨0.38%，近一年上涨6.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100030309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","06127","BK0216","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637036028","title":"昭衍新药早盘涨超7% 公司产能利用率维持在较高水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2637036028","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637036028?lang=zh_cn&edition=full","pubTime":"2026-05-21 10:40","pubTimestamp":1779331200,"startTime":"0","endTime":"0","summary":" 昭衍新药早盘涨超7%，截至发稿，股价上涨7.08%，现报21.02港元，成交额7631.46万港元。 据昭衍新药披露数据显示，昭衍新药2026年第一季度实现新签订单金额约9.1亿元，同比增长111.6%；截至一季度末，公司在手订单储备规模为31亿元，同比增长40.9%。公司在业绩说明会上透露，截至目前，第二季度订单的量价水平整体延续一季度态势。公司产能利用率维持在较高水平，但仍具备一定释放弹性，可灵活承接后续新增订单。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-05-21/doc-inhyrmmr6436557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06127","BK1141","BK0216","603127","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637489808","title":"异动快报：昭衍新药（603127）5月21日10点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2637489808","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637489808?lang=zh_cn&edition=full","pubTime":"2026-05-21 10:15","pubTimestamp":1779329728,"startTime":"0","endTime":"0","summary":"证券之星5月21日盘中消息，10点14分昭衍新药触及涨停板。其所属行业医疗服务目前上涨。该股为健康中国，CAR-T疗法，创新药概念热股，当日健康中国概念上涨1.95%，CAR-T疗法概念上涨1.85%，创新药概念上涨1.77%。5月20日的资金流向数据方面，主力资金净流出4624.47万元，占总成交额3.85%，游资资金净流入790.48万元，占总成交额0.66%，散户资金净流入3833.99万元，占总成交额3.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100013614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK1576","BK1141","BK0216","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636897358","title":"食蟹猴供应仍然偏紧！昭衍新药一季度新签订单金额增长111.6%，核心业务亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2636897358","media":"红星资本局","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636897358?lang=zh_cn&edition=full","pubTime":"2026-05-20 11:36","pubTimestamp":1779248205,"startTime":"0","endTime":"0","summary":"红星资本局5月20日消息，5月19日，“猴茅”昭衍新药（603127.SH；06127.HK）召开2026年第一季度业绩说明会，就投资者关心的业绩表现、订单情况、实验猴价格趋势等问题进行了回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203743242061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","BK1141","BK1576","603127","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636950858","title":"芯片下沉，AI硬件全面开花","url":"https://stock-news.laohu8.com/highlight/detail?id=2636950858","media":"钛媒体","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636950858?lang=zh_cn&edition=full","pubTime":"2026-05-20 08:28","pubTimestamp":1779236880,"startTime":"0","endTime":"0","summary":"端侧AI芯片是全球半导体行业增长最迅猛的板块之一，AI眼镜、AI耳机、AI玩具等新兴硬件品类对端侧芯片有着强劲需求。可以说，没有这些芯片厂商的技术突破和成本下探，就没有AI硬件的万亿叙事。这一判断的实践落地，在2026年的芯片端得到了全面回应。当这两条路线同时在芯片层面得到实现，AI硬件的临界点才真正到来。以Plaud为代表的AI录音硬件年营收达2.5亿美元，连续两年实现10倍增长，全球销量已突破百万台规模。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8tH431vOMtq","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["603893","688012","BK4535","300458","603127","06127","BK4588","QCOM","BK4585"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2636694900","title":"每周股票复盘：昭衍新药（603127）将召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2636694900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636694900?lang=zh_cn&edition=full","pubTime":"2026-05-17 01:07","pubTimestamp":1778951230,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，昭衍新药报收于39.96元，较上周的38.61元上涨3.5%。本周，昭衍新药5月15日盘中最高价报41.75元。会议审议包括2025年年度报告、利润分配、董事薪酬、董事会换届、修订公司章程、A股股权激励计划等议案。股权登记日为2026年5月28日，A股股东可参会。H股股东参会事项另行通知。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","603127","BK1576","06127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635771239","title":"港股午评|恒生指数早盘跌0.87% 机器人板块逆市大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2635771239","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635771239?lang=zh_cn&edition=full","pubTime":"2026-05-15 12:00","pubTimestamp":1778817625,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数跌0.87%，跌229点，报26159点；恒生科技指数跌1.26%。港股早盘成交1511亿港元。机器人产业进入量产博弈阶段。均胜电子涨6%，公司聚焦机器人核心部件以及相关总成方案。通用Token降价引爆市场需求，迅策垂类Token溢价及需求坚挺。阿里健康跌超6%，年度经调整净利同增19.3%，公司CFO发生变更。建滔积层板跌4.87%，中国巨石宣布扩产，花旗料短期或对公司造成负面市场情绪。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02833","02715","01888","603986","HHImain","002747","03986","HSTECH","01801","HSI","603127","00241","03317","003021","02591","06127","01208","02692","600362","00358","BK4588","513600","00699","MCHmain","02432","BK4585","600699","BK1183","BK1116"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635177564","title":"港股异动 | 昭衍新药(06127)逆市涨超7% 一季度归母净利同比增近4.8倍 新签订单延续高景气度增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2635177564","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635177564?lang=zh_cn&edition=full","pubTime":"2026-05-15 10:13","pubTimestamp":1778811183,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，昭衍新药逆市涨超7%，截至发稿，涨7.42%，报21.26港元，成交额1.22亿港元。消息面上，近日，昭衍新药发布2026年第一季度报告，营业收入3.16亿元，同比增加10.02%；归母净利润2.38亿元，同比增加479.67%；基本每股收益0.32元。华西证券指出， 26Q1新签订单为9.1亿元，同比增长111.6%，截止期末在手订单为31亿元，同比增长40.9%，为未来业绩增长奠定基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","603127","06127","BK1576","VXUS","BK1141","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635775323","title":"异动快报：昭衍新药（603127）5月15日9点46分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2635775323","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635775323?lang=zh_cn&edition=full","pubTime":"2026-05-15 10:03","pubTimestamp":1778810602,"startTime":"0","endTime":"0","summary":"证券之星5月15日盘中消息，9点46分昭衍新药触及涨停板。其所属行业医疗服务目前上涨。该股为AI医疗，基因编辑，CAR-T疗法概念热股，当日AI医疗概念上涨0.54%，基因编辑概念上涨0.49%，CAR-T疗法概念上涨0.47%。5月14日的资金流向数据方面，主力资金净流出7887.17万元，占总成交额7.33%，游资资金净流入1527.7万元，占总成交额1.42%，散户资金净流入6359.46万元，占总成交额5.91%。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/15/20260515457789.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/15/20260515457789.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260515/32226908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["06127","603127","BK1576","BK1141","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218590","title":"昭衍新药(06127)将于8月4日派发末期股息每股0.12元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218590","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634218590?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:57","pubTimestamp":1778583454,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，该公司将于2026年8月4日派发末期股息每股0.12元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK4588","BK1576","VIG","BK0216","BK4585","06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634411822","title":"每周股票复盘：昭衍新药（603127）H股A股股本无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634411822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634411822?lang=zh_cn&edition=full","pubTime":"2026-05-10 01:14","pubTimestamp":1778346853,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，昭衍新药报收于38.61元，较上周的38.87元下跌0.67%。本周，昭衍新药5月7日盘中最高价报40.79元。公司公告汇总H股公告：4月月报表北京昭衍新药研究中心股份有限公司提交截至2026年4月30日的证券变动月报表。公司H股和A股的法定/注册股本及已发行股份在本月无变动。H股总数为118,995,206股，于香港联交所上市；A股总数为630,353,014股，其中已发行股份627,179,094股，库存股3,173,920股。确认H股公众持股量符合上市规则要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","399300","BK1576","BK0216","159982","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633783039","title":"股市必读：昭衍新药一季报 - 第一季度单季净利润同比增长479.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633783039","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633783039?lang=zh_cn&edition=full","pubTime":"2026-05-06 06:17","pubTimestamp":1778019433,"startTime":"0","endTime":"0","summary":"当日关注点来自：昭衍新药2026年一季度归母净利润达2.38亿元，同比增长479.67%。业绩披露要点财务报告昭衍新药2026年一季报显示，一季度公司主营收入3.16亿元，同比上升10.02%；归母净利润2.38亿元，同比上升479.67%；扣非净利润2.17亿元，同比上升747.12%；负债率14.74%，投资收益457.07万元，财务费用-1281.63万元，毛利率20.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600004236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632255046","title":"每周股票复盘：昭衍新药（603127）Q1净利增479.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632255046","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632255046?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:52","pubTimestamp":1777675930,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，昭衍新药报收于38.87元，较上周的37.61元上涨3.35%。本周关注点来自业绩披露要点：昭衍新药2026年一季报显示归母净利润2.38亿元，同比上升479.67%。北京昭衍新药研究中心股份有限公司发布2026年A股限制性股票激励计划激励对象名单，共计283名核心技术人员和业务骨干入选。北京昭衍新药研究中心股份有限公司于2026年4月30日根据股份激励计划向12名选定参与者授予共1,430,000股H股奖励股份，发行价为零。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","603127","06127","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632667227","title":"昭衍新药（603127）2026年一季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2632667227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632667227?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:23","pubTimestamp":1777587815,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期昭衍新药发布2026年一季报。根据财报显示，昭衍新药营收净利润同比双双增长。截至本报告期末，公司营业总收入3.16亿元，同比上升10.02%，归母净利润2.38亿元，同比上升479.67%。广州设施的土建工作早已完成，并已通过竣工验收，后续将根据公司战略规划及业务需求逐步释放产能，预计于2027年投入使用。我们预计全年新签订单将保持双位数增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100005130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631168763","title":"昭衍新药（603127）披露2026年A股限制性股票激励计划（草案），4月30日股价上涨0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631168763","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631168763?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:07","pubTimestamp":1777543628,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，昭衍新药报收于38.87元，较前一交易日上涨0.6%，最新总市值为291.27亿元。该股当日开盘39.02元，最高39.98元，最低36.0元，成交额达19.09亿元，换手率为7.94%。公司于近日披露《2026年A股限制性股票激励计划（草案）》，拟授予316.7300万股限制性股票，占公司总股本的0.42%，股票来源为二级市场回购。本激励计划有效期最长不超过48个月，限售期分别为12个月、24个月、36个月，解除限售比例分别为40%、40%、20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000058528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","399300","BK1576","BK0216","159982","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631018591","title":"昭衍新药(06127)一季度归母净利润2.38亿元 同比增加479.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631018591","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631018591?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:17","pubTimestamp":1777457867,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布2026年第一季度报告，营业收入3.16亿元(人民币，下同)，同比增加10.02%;归母净利润2.38亿元，同比增加479.67%;基本每股收益0.32元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436324.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630056375","title":"4月28日昭衍新药涨7.31%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630056375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630056375?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:23","pubTimestamp":1777364615,"startTime":"0","endTime":"0","summary":"证券之星消息，4月28日昭衍新药涨7.31%，收盘报39.95元，换手率9.65%，成交量60.83万手，成交额23.86亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共44家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为32.51亿元，最新净值3.99，较上一交易日上涨0.66%，近一年上涨16.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800048830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","06127","BK1576","603127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630132145","title":"别只盯着AI！CXO龙头绩后狂飙，医药赛道要接棒？","url":"https://stock-news.laohu8.com/highlight/detail?id=2630132145","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630132145?lang=zh_cn&edition=full","pubTime":"2026-04-28 12:12","pubTimestamp":1777349565,"startTime":"0","endTime":"0","summary":"新一轮行情蓄势待发？","market":"hk","thumbnail":"https://img3.gelonghui.com/24523-2e652654-d4de-433f-93f9-afc3a2669c93.jpg?guru_height=718&guru_width=1280&guru_size=85166","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/24523-2e652654-d4de-433f-93f9-afc3a2669c93.jpg?guru_height=718&guru_width=1280&guru_size=85166"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4574522","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["159938","BK1576","09939","LU1046422090.SGD","LU0348766576.USD","BK0239","CHAT","LU0708995583.HKD","BK0216","LU0320764599.SGD","LU0348767384.USD","06821","LU2045819591.USD","BK1574","AIPO","BK1141","LU2125910500.SGD","02359","AGIX","002821","LU1328615791.USD","LU2242644610.SGD","ARTY","BK0132","BK1583","BK1191","603127","06127","LU0052750758.USD","CXO","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628375688","title":"每周股票复盘：昭衍新药（603127）将发布一季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2628375688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628375688?lang=zh_cn&edition=full","pubTime":"2026-04-19 01:10","pubTimestamp":1776532215,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，昭衍新药报收于36.93元，较上周的38.28元下跌3.53%。本周，昭衍新药4月15日盘中最高价报39.97元。4月13日盘中最低价报35.51元。昭衍新药当前最新总市值276.73亿元，在医疗服务板块市值排名7/51，在两市A股市值排名783/5198。公司公告汇总H股公告：董事会召开日期北京昭衍新药研究中心股份有限公司董事会宣布，将于2026年4月29日举行董事会会议，以考虑及通过本集团截至2026年3月31日止三个月之第一季度业绩及其发布。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","06127","BK1141","BK1576","603127"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779394791404,"stockEarnings":[{"period":"1week","weight":0.127},{"period":"1month","weight":0.1442},{"period":"3month","weight":0.1861},{"period":"6month","weight":0.5609},{"period":"1year","weight":1.5285},{"period":"ytd","weight":0.2217}],"compareEarnings":[{"period":"1week","weight":-0.0241},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0012},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2036},{"period":"ytd","weight":0.0273}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京昭衍新药研究中心股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2017-08-25","address":"北京市大兴区北京经济技术开发区荣京东街甲5号","registeredCapital":"74934万元","survey":" 北京昭衍新药研究中心股份有限公司的主营业务是以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是。公司同时具备中国NMPA、美国FDA、经合组织OECD、韩国MFDS、日本PMDA等GLP资质；2025年9月公司北京及太仓设施通过了OECD的GLP现场检查及复查。","listedPrice":12.51},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,603127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}